[Thrombocytopenia associated with sodium polystyrene sulfonate]. 1997

Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
Department of Internal Medicine, Naganuma Municipal Hospital.

A 84-year-old man was admitted with diabetes mellitus, hypertension and chronic renal failure in September 1994. In October 1995, his renal function gradually worsened with hyperkalemia. Sodium polystyrene sulfonate (Kayexalate) was administered orally for the treatment of hyperkalemia. However, after 7 days from the start of Kayexalate therapy, thrombocytopenia progressed gradually, and 12 days later the initial platelet count of 20.7 x 10(4)/microliter decreased to 8.6 x 10(4)/microliter. This thrombocytopenia rapidly improved after cessation of Kayexalate administration. In December 1995, readministration of Kayexalate for the treatment of hyperkalemia induced thrombocytopenia again. Bone marrow aspiration biopsy revealed normal counts of nucleated cells and megakaryocytes with no increase in blasts. No other disorders which cause thrombocytopenia were seen in this patient. The complication of thrombocytopenia associated with Kayexalate has not been reported. This is the first reported case of thrombocytopenia caused by Kayexalate administration.

UI MeSH Term Description Entries
D008297 Male Males
D011137 Polystyrenes Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads. Polystyrol,Polystyrene,Polystyrols
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006947 Hyperkalemia Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed) Hyperpotassemia,Hyperkalemias,Hyperpotassemias
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias

Related Publications

Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
January 2018, Diagnostic and interventional imaging,
Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
May 2021, ACG case reports journal,
Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
September 2020, Proceedings (Baylor University. Medical Center),
Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
March 1998, The American journal of surgical pathology,
Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
February 1982, Archives of internal medicine,
Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
April 1993, Neonatal network : NN,
Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
September 2013, The American journal of medicine,
Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
December 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
January 2005, Archives of pathology & laboratory medicine,
Y Mogi, and T Kura, and R Takimoto, and F Muto, and T Maeda, and H Muramatsu, and Y Niitsu
August 2019, JAMA internal medicine,
Copied contents to your clipboard!